Symbols

ZJYL

Jin Medical·NASDAQ

--(--)

7.52 / 10

Outperform

Analyst input is missing (ana_eval -1). Fund‑flow assessment is strong (7.52/10, good). Overall inflow ratio is 0.48 with small, medium and large investors net‑positive, though block and extra‑large flows are negative, indicating mixed but generally supportive capital interest.

Fund Flow Rating

What is the analyst consensus for ZJYL?

ZJYL holds a Neutral analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 7.52/10 (Outperform).